Phase 2
N=51
Heart and Hands Study II: A Retrospective Data Collection & Analysis Project
Thrombosis
Bottom Line
View on ClinicalTrials.gov: NCT02307318 ↗Enrolled (actual)
51
Serious AEs
0.0%
Results posted
Jan 2017
Primary outcome: Primary: Incidence of Arterial Bleeding — 1 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 2
- Interventions
- SoftSeal Hemostatic Pad (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- HealthEast Care System
- Primary completion
- Jun 2015
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Incidence of Arterial Bleeding |
1 | — |
| PRIMARY Incidence of Thrombosis |
— | — |
| SECONDARY Changes in Circulation, Movement and Sensation |
— | — |
| SECONDARY Incidence of Hematoma and/or Ecchymosis |
— | — |
Summary
A recent pilot study conducted at HealthEast found use of manual pressure with the SoftSeal hemostatic pad for 15 minutes was successful in 9 out of 10 people fully anticoagluated using 4 French radial sheath. There was no evidence of radial artery occlusion in this small sample and bleeding was limited to grade 1. This evidence supports a larger retrospective study to confirm these results and define an alternative to the TR band use post radial artery access for cardiac catheterization.
Primary Objective Determine the incidence of arterial bleeding after real-world use of SoftSeal hemostatic device at a transradial access site with a 4 French system with with manual pressure by compression of the ulnar artery.
Secondary Objective Determine the incidence of thrombosis at the access site in all subjects as presence of thrombus in the radial artery by reverse barbeau test; the incidence of changes in circulation, movement and sensation (CMS) in the hand and wrist on the impacted hand; and the incidence of hematoma and ecchymosis, assessed just prior to discharge.
Eligibility Criteria
Inclusion Criteria
- Transradial access site with a 4 French system ->18 years old
Exclusion Criteria
- Current oral anti-coagulation therapy
- Prior participation in this study
- Positive standard-of-care pregnancy test
- Investigator discretionary exclusions
- Patient on dialysis
- GFR <30
Data sourced from ClinicalTrials.gov (NCT02307318). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.